CALL FOR
ABSTRACTS

IMPORTANT DEADLINES

SEPTEMBER 17, 2025

Online submissions open

Submit an abstract today

DECEMBER 8, 2025

Deadline for abstract
submissions at 11:59 p.m. EST

LATE FEBRUARY 2026

Acceptance notifications for abstracts are sent via email

MARCH 16, 2026

Deadline to withdraw abstract (no refunds)

PRESENTATION TYPES

ORAL PRESENTATION

Oral Presentations may be scheduled beginning at 1:00 p.m. on Sunday, June 14 through Wednesday, June 17 and involve a 12-minute presentation window followed by 3-minutes for questions. The Program Committee reserves the right to assign abstracts that are not selected for an oral presentation to a poster presentation.

POSTER PRESENTATION

Poster Presentations involve display of a poster for one day on Monday, June 15; Tuesday, June 16; or Wednesday, June 17. Presenting authors are expected to be physically present at the poster display to answer questions during their assigned morning time slot. Poster presentations will be scheduled in one of two slots from 10:00 a.m. to 11:45 a.m. each day. Selection of a poster presentation at the time of submission indicates that you are only interested in presenting your work in this format. The Program Committee will not designate any abstract submitted for poster presentation as an oral presentation.

BOTH ORAL AND POSTER PRESENTATION

Both Oral and Poster Presentation provide authors the opportunity to present BOTH an oral presentation and poster presentation, based on the times and qualifications listed above. By selecting “Both Oral and Poster Presentation,” the author agrees to give BOTH an oral presentation and a poster presentation of the same work. The Program Committee reserves the right to assign abstracts that are not selected for an oral presentation to a poster presentation. To be considered for an oral presentation OR a poster presentation but NOT both, select the appropriate category as described above.

ABSTRACT CATEGORIES

Authors are required to select whether their abstract relates to the Basic and Translational Sleep and Circadian Science track or the Clinical Sleep Science and Practice track when submitting their abstracts. The APSS Program Committee reserves the right to move abstracts between tracks and categories as it sees fit.

Basic and Translational Sleep and Circadian Science
This category includes basic research on the fundamental aspects of sleep and circadian science from animal models to humans as well as translational research on fundamental mechanisms to understand disease and discover treatments. 

e.g. Phase 1 trials, studies on healthy populations, etc.

  • Circadian rhythms
  • Cell and molecular biology and genetics
  • Neurobiology
  • Learning, memory, and cognition
  • Peripheral physiology
  • Emotion, stress, and trauma
  • Behavior, performance, and fatigue
  • Sleep deprivation, loss, and extension
  • Sleep and chronobiology across the lifespan
  • Development
  • Aging
  • Sleep and circadian disparities
  • Human and translational models
  • Innovations in technologies
  • Occupations and populations

Clinical Sleep Science and Practice

This category includes a focus on clinical practice, policy, populations, or research with an immediate or direct clinical application.

e.g. Phase 2-3 trials, studies on clinical populations, etc.

  • Insomnia
  • Pathophysiology, epidemiology, diagnosis
  • Treatment
  • Sleep-related breathing disorders
  • Pathophysiology
  • Epidemiology/diagnosis
  • Treatment
  • Hypersomnia
  • Epidemiology and diagnosis
  • Treatment
  • Circadian rhythm sleep-wake disorders
  • RLS, movement disorders, and parasomnias
  • Adults: Sleep and aging, sleep and gender
  • Pediatrics
  • Sleep-related breathing disorders
  • Insomnia and behavioral sleep problems
  • Other
  • Sleep and medical disorders
  • Sleep and cardiovascular comorbidities
  • Sleep and non-cardiovascular comorbidities
  • Sleep and psychiatric disorders
  • Nightmares, abnormal dreams, and PTSD
  • Mood and anxiety disorders
  • Other
  • Sleep and neurologic disorders
  • Healthcare delivery and implementation
  • Education
  • Consumer technology

Additional Submission Information

  • Abstract presentations are scheduled at the sole discretion of the APSS Program Committee. Submission of an abstract constitutes the commitment of at least one author to present the abstract as accepted, regardless of presentation type or day/time assigned.
  • Expenses associated with the preparation, submission and presentation of an abstract are the responsibility of the author/presenter.
  • Abstract presenters must register for the meeting. Registration instructions for the meeting will be included with the notice of acceptance.
  • Case reports and literature reviews are not appropriate and will not be considered.
    Click here for information about case report submissions.
  • Abstracts will not be accepted for presentation if they fail to reflect acceptable scientific methodology, if the data or statistical analyses do not justify the conclusions, if they lack sufficient scientific or clinical merit, or if no data are included.
  • All abstracts are peer-reviewed; notice of acceptance will be sent to the contact author via email in late February 2026.

Submission Deadline: December 8, 2025, by 11:59 p.m. EST

Abstracts that do not meet all of the specifications listed below will be automatically rejected:

  • An individual may be the presenting author on a maximum of two abstracts.
  • There can be no more than fifteen (15) authors per abstract.
  • Abstracts must conform to the following outline. Abstract sections may not be substituted with different terminology:
    • Title
    • Authors and Institutions
    • Introduction
    • Methods
    • Results
    • Conclusion
    • Support (if any)
  • The abstract body (comprising introduction, methods, results, conclusion, and support) is limited to 350 words.
  • Brand names may not be used in abstract titles and are limited to one reference within the body.
  • References, tables, figures or any other graphics are not permitted.

Additionally, to comply with continuing education credit guidelines, the presenting author submitting an oral presentation will be required to disclose all relationships with ineligible companies over the previous 24 months. These disclosures must be detailed during the abstract submission process.

If the presenting author does not complete this disclosure process, the APSS will not be able to offer continuing education credit for your presentation. Authors of accepted poster presentations are not required to provide this information.

Ineligible companies are those whose primary business is producing, marketing, selling, re-selling or distributing health care products used by or on patients.

  • All abstracts must be submitted electronically via the SLEEP 2026 submission website.
  • Authors are encouraged to submit abstracts early. You will be able to revise, edit and preview your abstract until the close date of December 8, 2025 at 11:59 p.m. EST.
  • Please review your work for accuracy; abstracts will be printed exactly as submitted. Copyediting of your abstract will not be permitted.
  • To withdraw an abstract, the contact author of the abstract must provide written notification to the APSS Meeting Department by March 16, 2026.
  • A nonrefundable abstract review fee of $50 per submission must be paid at the time of submission. Review fees are nonrefundable for withdrawn abstracts.

Policies, Disclosures, and More

Authors are required to write an original abstract that fulfills accepted criteria for copyright purposes. Accepted abstracts will be published and copyrighted in a special issue of the journal SLEEP. By submitting an abstract, all authors attest that the abstract submitted has not been previously published elsewhere and transfers, assigns or otherwise conveys all copyright ownership, including any and all rights incidental thereto, exclusively to the Sleep Research Society as publisher of the journal SLEEP. 

If an author chooses to submit information from an abstract that has previously been presented and/or published, all data must be updated, current and rewritten in a manner that does not infringe on copyright laws. Authors are responsible for obtaining permission to include any copyrighted material in their abstract presentations. All authors will be required to agree to a copyright assignment statement when submitting an abstract. 

The Program Committee will give priority to research that has not been presented elsewhere or published prior to SLEEP 2026. 

The Sleep Research Society is pleased to offer Trainee Merit Awards that are based on abstract submissions. Complete information can be found at sleepresearchsociety.org/awards/conference-awards.

The American Academy of Sleep Medicine Foundation offers the Trainee Investigator Award. Additional details about this award can be found at foundation.aasm.org/award-programs/trainee-investigator-award/.

Continuing education credit will be provided to attendees of all challenging cases presentations. Each presenting author is required to review and adhere to the conflict of interest disclosure policy. Additionally, the presenting author must complete the conflict of interest disclosure form during the submission process. 

SLEEP 2026 meeting activities have been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Sleep Medicine (AASM) and the Associated Professional Sleep Societies, LLC (APSS). The AASM is accredited by the ACCME to provide continuing medical education for physicians. 

To comply with the mandatory ACCME guidelines to offer continuing education credits, all session speakers must comply with the APSS conflict of interest policy. 

Prior to the activity, every speaker/presenting author must disclose to the APSS if they do or do not have
financial relationship(s) with one or more ineligible companies. The following information must be submitted for
each speaker/presenting author:

  • Their role in the educational event
  • The name(s) of any ineligible companies with which the individual has a financial relationship(s) within the prior 24 months
  • The nature of the relationship(s), and whether or not the relationship has ended

An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. For specific examples of ineligible companies visit accme.org/standards.

The accredited provider is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies while managing these conflicts to ensure they do not introduce commercial bias into the education. Financial relationships of any dollar amount during the past 24 months are defined as relevant if the educational content is related to the business lines or products of the ineligible company.

The nature of the relationship(s) is defined as financial relationships in which the individual benefits by receiving income, salary, royalty, intellectual property rights, consulting fees, honoraria, or other financial benefits. Financial benefits are typically associated with roles such as employment, consulting, investigational or contract research, speaking/teaching, membership on advisory committees or review panels, board membership, and other activities from which compensation is received or expected.

Additionally, speakers cannot promote any ineligible companies during their presentation. This includes displaying logos and/or advertising in their presentations. Speakers cannot promote any other educational programs or events during their presentation.

If a speaker/author does not comply with the APSS Conflict of Interest Policy, the individual will not be permitted to participate in the program and may be banned from participating in future meetings. The APSS Program Committee will review the disclosures of financial relationships and the topic of the session to ensure compliance with the requirements stated above.

To comply with some requirements, presentation slides may be requested from a speaker in advance of the meeting depending on their disclosed conflicts.

Speakers must disclose any financial relationships with ineligible companies during the submission process. Instructions on this will be provided during the submission process and information on disclosing these relationships during your presentation will be provided prior to the meeting.

Abstracts remain under embargo until the publication of the SLEEP journal abstract supplement, typically in mid-May. Content from oral presentations and posters is embargoed until the conclusion of their scheduled presentation date and time.

GOT QUESTIONS?

CONTACT US!

Please submit any questions to:
Associated Professional Sleep Societies, LLC
Attn: Meeting Department

Phone: (630) 737-9700
Email: [email protected]